← All stocks

Vera Therapeutics, Inc.

VERA Scheduled selling only

CIK 0001831828 #1966 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$649.64K

$0.00 on a plan · $649.64K straight out of an exercise

Sold at will

$0.00

0 of 1 sales

Net

−$649.64K

$0.00 against sales at will

By person

12 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fordyce Marshall

PRESIDENT AND CEO

—

$649.64K (1) scheduled

−$649.64K

235,244

0.3264%

$8.26M

+37.7%

ENRIGHT PATRICK G

Director

—

3,602,475

5.00%

$126.50M

+7.6%

SEIDENBERG BETH C

Director

—

135,565

0.1881%

$4.76M

−18.8%

Grant Sean

CHIEF FINANCIAL OFFICER

—

114,181

0.1584%

$4.01M

+69.8%

Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCR

—

80,754

0.1121%

$2.84M

+52.0%

Skelton Laurence Matthew

Chief Commercial Officer

—

64,218

0.0891%

$2.26M

+40.2%

Brenner Robert

Chief Medical Officer

—

50,947

0.0707%

$1.79M

+4,153%

Carter Jason S

Chief Legal Officer

—

49,136

0.0682%

$1.73M

—

JOHNSON DAVID LEE

Chief Operating Officer

—

45,727

0.0635%

$1.61M

+3,152%

Turner William D.

Chief Regulatory Officer

—

45,313

0.0629%

$1.59M

—

Boman Nancy Lee

Chief Regulatory Officer

—

44,987

0.0624%

$1.58M

—

Wright-Mitchell Jane

Chief Legal Officer

—

42,403

0.0588%

$1.49M

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 1

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 23,500

History held since 17 May 2021